KMDA
Kamada Ltd.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · IL
$8.54
+3.26%Forward multiples
Based on analyst estimates
- P/E forward
- 17.17x
- P/E 2026E
- 17.44x
- P/E 2027E
- 14.25x
- P/E 2028E
- 12.50x
- P/S forward
- 2.34x
Trailing multiples
Trailing twelve months
- P/E TTM
- 22.30x
- PEG TTM
- 0.74x
- Price / book
- 1.83x
- Price / sales
- 2.57x
- Price / cash flow
- 13.68x
Enterprise value
- Enterprise value
- $434.4M
- EV / sales
- 2.26x
- EV / EBITDA
- 10.35x
- EV / EBIT
- 15.61x
- Market cap
- $492.7M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026